The DOI matches its Crossref record.
Induction of p53-mediated apoptosis and recovery of chemosensitivity through p53 transduction in human glioblastoma cells by cisplatin
Open accessAbstract
Cisplatin is a DNA-damaging chemotherapeutic drug that may have a role in the adjuvant chemotherapy of several solid tumors, such as malignant glioblastoma, and the status of p53 tumor suppressor protein is a critical determinant of cisplatin chemosensitivity. In the present study, we showed the relationship of p53 status and chemosensitivity of cisplatin between two human malignant glioblastoma cell lines, A172 and T98G, harboring wild-type and mutant-type p53, respectively. Cisplatin was found to be more cytotoxic to A172 than T98G cells in a time- and concentration-dependent manner. Cisplatin-induced cytotoxicity manifested as apoptosis, characterized by genomic DNA fragmentation, nuclear condensation and an increase in sub-G1 population. Cisplatin induced the accumulation of p53 and p21 proteins in A172 cells, but not in T98G cells. The introduction of the adenovirus-mediated wild-type p53 gene into T98G cells resulted in the decrease of viability as well as the increase in sub-G1 population with p53 accumulation, activation of caspase-3 protease and release of cytochrome c from the mitochondria. These data strongly suggest that the expression of p53 is essential for the cytotoxic effect of cisplatin in human malignant glioblastoma cells, A172 and T98G, and the introduction of apoptotic signal molecules, such as p53, will be beneficial to achieve chemosensitivity in malignant glioma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 inactivation is correlated with a more invasive [30], less apoptotic [31], more proliferative [27], and more stem-like [28] phenotype.”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [31]
In the citing paper
“GBM cell lines possessing inactivated mutant p53 (mut-p53) are more resistant to DNA-damaging therapeutic drugs, such as cisplatin [31].”
From The p53 Pathway in Glioblastoma (2018) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Still being checked.
Research works printed but not linked: 1
- Mazzatti DJ, Lee YJ, Helt CE, O'Reilly MA and Keng PC: p53 modulates radiation sensitivity independent of p21 transcriptional activation. Am J Clin Oncol 28: 43-50, 2005.
Cited by
Florea, A.-M., & Büsselberg, D. (2011) · Cancers · doi:10.3390/cancers3011351 · Cited by 1,759
Epidemiology of Glioblastoma Multiforme–Literature Review
Grochans, S., Cybulska, A. M., Simińska, D., Korbecki, J., Kojder, K., Chlubek, D., & Baranowska-Bosiacka, I. (2022) · Cancers · doi:10.3390/cancers14102412 · Cited by 630
The p53 Pathway in Glioblastoma
Zhang, Y., Dube, C., Gibert, M., Cruickshanks, N., Wang, B., Coughlan, M., Yang, Y., Setiady, I., Deveau, C., Saoud, K., et al. (2018) · Cancers · doi:10.3390/cancers10090297 · Cited by 440
Rocha, C. R. R., Garcia, C. C. M., Vieira, D. B., Quinet, A., de Andrade-Lima, L. C., Munford, V, Belizário, J. E., & Menck, C. F. M. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.465 · Cited by 164
Lulla, R. R., Goldman, S., Yamada, T., Beattie, C. W., Bressler, L. R., Pacini, M., Pollack, I. F., Fisher, P. G., Packer, R. J., Dunkel, I. J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now047 · Cited by 152
Review: Ototoxic Characteristics of Platinum Antitumor Drugs
Ding, D., Allman, B. L., & Salvi, R. (2012) · The Anatomical Record · doi:10.1002/ar.22577 · Cited by 144
Trejo‐Solís, C., Jiménez‐Farfán, D., Rodríguez‐Enríquez, S., Fernández‐Valverde, F., Cruz-Salgado, A., Ruíz-Azuara, L., & Sotelo, J. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-156 · Cited by 136
Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
Zhai, K., Mazuráková, A., Koklesová, L., Kubatka, P., & Büsselberg, D. (2021) · Biomolecules · doi:10.3390/biom11121841 · Cited by 85
Wang, G.-B., Wang, J. J., Chen, X. L., Du, S. M., Li, D. S., Pei, Z. J., Lan, H., & Wu, L. B. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.242 · Cited by 63
RetractedLesniak (2009) · International Journal of Oncology · doi:10.3892/ijo_00000199 · Cited by 48
Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
Trejo‐Solís, C., Castillo‐Rodríguez, R. A., Serrano-García, N., Silva‐Adaya, D., Vargas-Cruz, S., Chávez-Cortéz, E. G., Gallardo‐Pérez, J. C., Zavala-Vega, S., Cruz-Salgado, A., & Magaña-Maldonado, R. (2024) · Metabolites · doi:10.3390/metabo14050249 · Cited by 42
API5 induces cisplatin resistance through FGFR signaling in human cancer cells
Jang, H. S., Woo, S. R., Song, K., Cho, H., Chay, D. B., Hong, S.-O., Lee, H., Oh, S. J., Chung, J., Kim, J., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.130 · Cited by 41
Self-citationWang, G., Wang, J., Luo, J. D., Wang, L., Chen, X.-L., Zhang, L., & Jiang, S. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34607 · Cited by 40
RetractedAlves, S. R., Colquhoun, A., Wu, X. Y., & Silva, D. D. O. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110984 · Cited by 39
Gang, W., JunJie, W., HongMing, T., HuaFu, Z., & Wang, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s82282 · Cited by 37
RetractedHemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities
Haase, S., Núñez, F. M., Gauss, J. C., Thompson, S., Brumley, E. K., Lowenstein, P. R., & Castro, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249654 · Cited by 35
Carminati, P. O., Donaires, F. S., Marques, M. M. C., Donadi, E. A., Passos, G. A. S., & Sakamoto‐Hojo, E. T. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2849-z · Cited by 36
Tang, X., Huang, K.-M., Gui, H., Wang, J., Lu, J., Dai, L., Zhang, L., & Wang, G. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s114302 · Cited by 34
RetractedHuman papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma
Wang, J., Fang, C., Wang, M., Yu, M., Bai, K., Lu, P.-C., & Liu, H. E. (2013) · International Journal of Cancer · doi:10.1002/ijc.28349 · Cited by 34
Compagnin, C., Mognato, M., Celotti, L., Canti, G. L., Palumbo, G. A., & Reddi, E. (2010) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00673.x · Cited by 34
Tsai, H., Wei, K., Chen, P., Huang, C.-Y., Chen, K., Lin, Y.-J., Cheng, H.-W., Chen, Y.-R., & Wang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722754 · Cited by 34
PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage
Huang, B., Zhuo, J., Leung, C. H., Lu, G., Liu, J. J., Yap, C. T., & Hooi, S. C. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.180 · Cited by 33
Dorsey, J. F., Mintz, A., Tian, X., Dowling, M. L., Plastaras, J. P., Dicker, D. T., Kao, G. D., & El‐Deiry, W. S. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0415 · Cited by 33
Therapeutic effect of natural polyphenols against glioblastoma
Beylerli, O., Beilerli, A., Shumadalova, A. V., Wang, X., Yang, M., Sun, H., & Teng, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036809 · Cited by 32
Bhana, S., & Lloyd, D. R. (2007) · Mutagenesis · doi:10.1093/mutage/gem041 · Cited by 31
Tsutsumi, M., Miki, Y., Akimoto, J., Haraoka, J., Aizawa, K., Hirano, K., & Beppu, M. (2012) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2012.08.002 · Cited by 29
Wang, G., Wang, J., Wang, Y., Feng, S., Jing, G., & Fu, X. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1489825 · Cited by 30
RetractedSodium butyrate induces senescence and inhibits the invasiveness of glioblastoma cells
Nakagawa, H., Sasagawa, S., & Itoh, K. (2017) · Oncology Letters · doi:10.3892/ol.2017.7518 · Cited by 25
Rocha, C. R. R., Garcia, C. C. M., Vieira, D. B., Quinet, A., de Andrade-Lima, L. C., Munford, V., Belizário, J. E., & Menck, C. F. M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.101 · Cited by 25
Kim, H. I., Hong, S. H., Ku, J. M., Kim, M.-J., Ju, S. W., Chang, S. W., Cheon, C., & Ko, S. (2020) · Nutrients · doi:10.3390/nu12010196 · Cited by 24
Self-citationGenetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin
García-Rodríguez, F. J., Martínez-Fernández, C., Brena, D., Kukhtar, D., Serrat, X., Nadal, E., Boxem, M., Honnen, S., Miranda‐Vizuete, A., Villanueva, A., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033506 · Cited by 20
Umugire, A., Nam, Y. S., Nam, Y. E., Choi, Y. M., Choi, S. M., Lee, S., Cho, J. H., & Cho, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032947 · Cited by 19
Tallen, U. G., Truß, M., Kunitz, F., Wellmann, S. M., Unryn, B. M., Sinn, B., Laß, U., Krabbe, S., Holtkamp, N., Hagemeier, C., et al. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9436-x · Cited by 18
Carminati, P. O., Mello, S. S., Fachin, A. L., Junta, C. M., Sandrin‐Garcia, P., Carlotti, C. G., Donadi, E. A., Passos, G. A. S., & Sakamoto‐Hojo, E. T. (2010) · Genetics and Molecular Biology · doi:10.1590/s1415-47572010005000013 · Cited by 17
Agudo-López, A., Prieto‐García, E., Alemán, J., Pérez, C., Díaz-García, C. V., Parrilla‐Rubio, L., Cabrera, S., Navarro‐Ranninger, C., Cortés-Funes, H., Lopez-Martin, J. A., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0618-7 · Cited by 17
AnvirzelTMregulates cell death through inhibiting GSK-3 activity in human U87 glioma cells
Uşak, Ş. T., Nalli, A., Elibol, B., Özek, E., & Hatiboğlu, M. A. (2020) · Neurological Research · doi:10.1080/01616412.2019.1709744 · Cited by 16
Bhana, S., Hewer, A. J., Phillips, D. H., & Lloyd, D. R. (2008) · Mutagenesis · doi:10.1093/mutage/gen001 · Cited by 15
Vitamin C and diallyl sulfide as chemosensitizers to cisplatin in treating hepatocellular carcinoma
Abdel‐Hamid, N. M., Nazmy, M., & Nazmy, W. (2011) · Journal of Solid Tumors · doi:10.5430/jst.v1n3p90 · Cited by 12
Oxygen/Nitric Oxide Dual-Releasing Nanozyme for Augmenting TMZ-Mediated Apoptosis and Necrosis
Ma, J., Qiu, J., Wright, G. A., & Wang, S. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00817 · Cited by 12
Contreras-Ochoa, C. O., López‐Arellano, M. E., Roblero-Bartolon, G., Díaz‐Chávez, J., Moreno-Banda, G. L., Reyna-Figueroa, J., Munguía-Moreno, J., Madrid‐Marina, V., & Lagunas-Martínez, A. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119892041 · Cited by 11
p53 inhibits the Urea cycle and represses polyamine biosynthesis in glioma cell lines
Zhao, Y., Chen, Y., Wei, L., Ran, J., Wang, K., Zhu, S., & Liu, Q. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01173-y · Cited by 10
Cisplatin binds to the MDM2 RING finger domain and inhibits the ubiquitination activity
Cao, K., Ding, X., Sheng, Y., Wang, Y., & Liu, Y. (2020) · Chemical Communications · doi:10.1039/d0cc00203h · Cited by 9
p53-dependent radiobiological responses to internalised indium-111 in human cells
Weeks, A. J., Blower, P. J., & Lloyd, D. R. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.08.009 · Cited by 7
Effects of the Hypoxia-Mimetic Agents DFO and CoCl2 on HeLa-Fucci Cells
Bedessem, B. (2015) · Cell Biology & Cell Metabolism · doi:10.24966/cbcm-1943/100004 · Cited by 7
Tetz, V., Kardava, K. M., Vecherkovskaya, M. F., Khodadadi‐Jamayran, A., Tsirigos, A., & Tetz, G. V. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf085 · Cited by 5
Cho, S. B. (2020) · Entropy · doi:10.3390/e22121434 · Cited by 5
Cisplatin Toxicity in Children with Malignancy
Ruggiero, A., Trombatore, G., Triarico, S., Capozza, M. A., Coccia, P., Attinà, G., Mastrangelo, S., & Maurizi, P. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1791 · Cited by 5
Regulating white blood cell activity through the novel universal receptive system
Tetz, V., Kardava, K. M., Vecherkovskaya, M. F., Khodadadi‐Jamayran, A., Tsirigos, A., & Tetz, G. V. (2025) · Scientific Reports · doi:10.1038/s41598-025-21866-x · Cited by 5
Keshtmand, Z. (2018) · International Journal of Morphology · doi:10.4067/s0717-95022018000100140 · Cited by 4
Expression and clinical significance of RBBP4 gene in lower-grade glioma: An integrative analysis
Liang, R., Xiang, Y., Hu, C., & Tang, X. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101533 · Cited by 3
Skredėnienė, R., Stakišaitis, D., Valančiūtė, A., & Balnytė, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146784 · Cited by 3
Tokhtueva, M. D., Melekhin, V. V., Abramov, V. M., Ponomarev, A. I., Prokofyeva, A., Grzhegorzhevskii, K. V., Paramonova, A. V., Makeev, O. G., & Eltsov, O. S. (2024) · BioMetals · doi:10.1007/s10534-024-00646-6 · Cited by 2
Expression level comparison of marker genes related to early embryonic development and tumor growth
Cai, Q., Li, D.-L., Zhang, Y., Liu, Y., Pei, F., Zheng, S.-Q., Zhang, Y., Yang, Y., Hou, C., Gao, C.-W., et al. (2022) · Oncology Letters · doi:10.3892/ol.2022.13564 · Cited by 2
Massaro, R. R. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2009.tde-29092009-154905 · Cited by 2
p53-Induced ROS-accumulation induces programmed cell death in C6 glioma cells
Wang, G., Wang, J., Li, B., Sun, Y.-D., Ding, Z., & Ding, C. (2014) · International Conference on Information Science, Electronics and Electrical Engineering · doi:10.1109/infoseee.2014.6948063
Knebel, F. H. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2014.tde-27052015-114441 · Cited by 1
Dorsey, J. F., Mintz, A., Tian, X., Dowling, M. L., Plastaras, J. P., Dicker, D. T., Kao, G. D., & El‐Deiry, W. S. (2023) · doi:10.1158/1535-7163.c.6531731.v1
Lillo, S. (2023) · theses.fr (ABES) · doi:10.70675/49be81c2z656fz400dzbc64z391cf8330a65
Gómez, S. V., Garro, J. M. M., Ortiz, L. D., Flórez, J. E. S., Monroy, F. P., & Sánchez, R. G. P. (2024) · Biomedicines · doi:10.3390/biomedicines12102287
Characterization of cellular heterogeneity in Diffuse Low Grade Glioma
Augustus, M. (2020) · theses.fr (ABES) · doi:10.70675/037c23a4z44ddz4bb7z999ezb0c178c35170
Boukredine, A. (2021) · theses.fr (ABES) · doi:10.70675/169b99afz5507z4d66zbbfazaaebacd91737 · Cited by 1
Metadata
- Authors
- Park, C.-M., Park, M.-J., Kwak, H.-J., Moon, S.-I., Yoo, D.-H., Lee, H.-C., Park, I.-C., Rhee, C. H., & Hong, S.-I.
- Affiliations
- Korea Institute of Radiological and Medical Sciences (KR)
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2006-01-01
- Volume
- 28
- Issue
- 1
- Pages
- 119-25
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W1996719655
- Cited by
- 58
- References
- 0
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 5
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, cisplatin, glioblastoma, apoptosis, chemosensitivity, wild-type p53, mutant p53, p21, caspase-3, cytochrome c release, DNA fragmentation, A172 cells, T98G cells
- MeSH terms
- Brain Neoplasms, Cisplatin, DNA Damage, Enzyme Activation, Glioblastoma, Humans, Transduction, Genetic, Tumor Cells, Cultured, Genes, p53, Tumor Suppressor Protein p53, Apoptosis, Caspases, Cytochromes c, Caspase 3, Caspase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.